Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Total article views   HTML views PDF downloads Totals
5,594 Dovepress* 5,369+ 183 5,552
PubMed Central* 225 104 329
Totals 5,594 287 5,881
*Since 13 November 2021

View citations on PubMed and Google Scholar